What is the dosage and treatment duration of Bactrim (trimethoprim/sulfamethoxazole) for bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trimethoprim/Sulfamethoxazole (Bactrim) Dosage and Treatment Duration for Bacterial Infections

For bacterial infections, trimethoprim-sulfamethoxazole (Bactrim) is typically dosed as 1-2 double-strength tablets (160mg/800mg) twice daily for adults, with treatment duration ranging from 5-14 days depending on the specific infection type. 1

Adult Dosing Recommendations

Oral Administration

  • Standard adult dose: 1-2 double-strength tablets (160mg/800mg) twice daily 2
  • Duration by infection type:
    • Urinary tract infections: 10-14 days 1
    • Skin and soft tissue infections: 7 days (depending on clinical response) 2
    • Acute exacerbations of chronic bronchitis: 14 days 1
    • Traveler's diarrhea: 5 days 1
    • Shigellosis: 5 days 1

Intravenous Administration

  • Dosage: 8-12 mg/kg/day (based on trimethoprim component) in 4 divided doses 2

Pediatric Dosing Recommendations

  • Standard pediatric dose: 8-12 mg/kg/day (based on trimethoprim component) in either 4 divided doses IV or 2 divided doses PO 2
  • For children ≥2 months of age (weight-based dosing) 1:
    • 10 kg: 1 teaspoonful (5 mL) every 12 hours
    • 20 kg: 2 teaspoonfuls (10 mL) every 12 hours
    • 30 kg: 3 teaspoonfuls (15 mL) every 12 hours
    • 40 kg: 4 teaspoonfuls (20 mL) every 12 hours
  • Duration: Same as adults based on infection type
  • Note: Contraindicated in children less than 2 months of age 1

Special Indications

Pneumocystis jirovecii Pneumonia

  • Treatment dose: 75-100 mg/kg/day sulfamethoxazole and 15-20 mg/kg/day trimethoprim in equally divided doses every 6 hours for 14-21 days 1
  • Prophylaxis dose:
    • Adults: 1 double-strength tablet daily 1
    • Children: 750 mg/m²/day sulfamethoxazole with 150 mg/m²/day trimethoprim in equally divided doses twice daily, 3 consecutive days per week 1

MRSA Skin and Soft Tissue Infections

  • Dosage: 1-2 double-strength tablets twice daily 2
  • Duration: 7 days (depending on clinical response) 2

Dosage Adjustment for Renal Impairment

  • CrCl >30 mL/min: Standard regimen
  • CrCl 15-30 mL/min: Half the usual regimen
  • CrCl <15 mL/min: Not recommended 1

Clinical Considerations and Cautions

  • TMP-SMX is bactericidal but has limited published efficacy data for some infections 2
  • Consider resistance patterns in your geographic area before prescribing, as resistance has increased over time 3
  • Monitor for adverse effects, particularly with longer treatment courses:
    • Common side effects include rash, gastrointestinal disturbances, and photosensitivity
    • Serious but rare effects include bone marrow suppression, Stevens-Johnson syndrome, and hepatotoxicity 4
  • For skin and soft tissue infections, surgical drainage remains the primary treatment for purulent infections, with TMP-SMX as adjunctive therapy 5

Pitfalls to Avoid

  1. Inappropriate duration: Avoid underdosing or extending treatment unnecessarily
  2. Use in contraindicated populations: Do not use in children <2 months, pregnant women near term, or patients with severe renal impairment
  3. Failure to adjust for renal function: Always check creatinine clearance and adjust dosing accordingly
  4. Ignoring resistance patterns: Consider local resistance patterns before prescribing
  5. Drug interactions: Be aware of potential interactions with warfarin, phenytoin, methotrexate, and other medications

By following these guidelines, you can optimize the use of trimethoprim-sulfamethoxazole for bacterial infections while minimizing the risk of treatment failure and adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Resistance to trimethoprim-sulfamethoxazole.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001

Research

Trimethoprim-sulfamethoxazole in the United States.

Annals of internal medicine, 1979

Guideline

Antibiotic Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.